The Tetrahedron Journal for Research at the Interface of Chemistry and BiologyBioorganic & Medicinal Chemistry publishes complete accounts of research of outstanding significance and timeliness on all aspects of molecular interactions at the interface of chemistry and biology, together with critical review articles. The journal publishes reports of experimental results in medicinal chemistry, chemical biology and drug discovery and design, emphasizing new and emerging advances and concepts in these fields. The aim of the journal is to promote a better understanding at the molecular level of life processes, and living organisms, as well as the interaction of these with chemical agents.The Journal welcomes papers on:the medicinal chemistry and associated biology (including target identification and validation) of established or new disease targetsthe reporting of the discovery, design or optimization of potent new compounds or biological agentsthe analysis and discussion of structure-activity relationships and pharmacological issues relevant to drug design and action using in vitro and in vivo models, including the use of computational techniques when closely linked to experimental datathe reporting of "first-in-class" new therapeutic compoundsthe chemical biology or bioorganic/bioinorganic chemistry that significantly advances knowledge of a biological mechanismmethodological advances that are chemistry-based and which significantly impact on medicine or biologythe preparation and examination of biotherapeutics for the treatment of pathophysiological disease statesthe development of materials for specific therapeutic targetingAll manuscripts will be rigorously peer-reviewed by independent experts following an initial assessment by the Editors. Please note that BMC is not suitable for straightforward reports of incremental advances. Above all the presentation of a rational basis and a sound underlying hypothesis for the work is of particular importance, whatever its exact field.
BMCL (Bioorganic & Medicinal Chemistry Letters) publishes research communications of outstanding significance and timeliness on topics at the interface of chemistry and biology, together with concise review articles and perspectives. BMCL publishes reports of experimental results in medicinal chemistry, chemical biology and drug discovery and design, emphasizing new and emerging advances and concepts in these fields. The aim of BMCL is to promote a better understanding at the molecular level of life processes, and living organisms, as well as the interaction of these with chemical agents. BMCL continues to be a major forum for the first publication of new chemical entities prior to them entering clinical trials.BMCL welcomes papers on: the medicinal chemistry and associated biology (including target identification and validation) of established or new disease targetsThe reporting of the discovery, design or optimization of potent new compounds or biological agentsthe analysis and discussion of structure-activity relationships and pharmacological issues relevant to drug design and action using in vitro and in vivo models, including the use of computational techniques when closely linked to experimental datathe reporting of "first-in-class" new therapeutic compoundsthe chemical biology or bioorganic/bioinorganic chemistry that significantly advances knowledge of a biological mechanismmethodological advances that are chemistry-based and which significantly impact on medicine or biologythe preparation and examination of biotherapeutics for the treatment of pathophysiological disease statesthe development of materials for specific therapeutic targetingManuscripts on phytochemistry, theoretical molecular dynamics and exclusively computational papers are out of scope. All manuscripts will be rigorously peer-reviewed by independent experts following an initial assessment by the Editors. Please note that BMCL is not suitable for straightforward reports of incremental advances. Above all the presentation of a rational basis and a sound underlying hypothesis for the work is of particular importance, whatever its exact field.
Bioorganic Chemistry publishes research that addresses biological questions at the molecular level, using organic chemistry and principles of physical organic chemistry. The scope of the journal covers a range of topics at the organic chemistry-biology interface, including: enzyme catalysis, biotransformation and enzyme inhibition; nucleic acids chemistry; medicinal chemistry; natural product chemistry, natural product synthesis and natural product biosynthesis; antimicrobial agents; lipid and peptide chemistry; biophysical chemistry; biological probes; bio-orthogonal chemistry and biomimetic chemistry.For manuscripts dealing with synthetic bioactive compounds, the Journal requires that the molecular target of the compounds described must be known, and must be demonstrated experimentally in the manuscript. For studies involving natural products, if the molecular target is unknown, some data beyond simple cell-based toxicity studies to provide insight into the mechanism of action is required. Studies supported by molecular docking are welcome, but must be supported by experimental data. The Journal does not consider manuscripts that are purely theoretical or computational in nature.The Journal publishes regular articles, short communications and reviews. Reviews are normally invited by Editors or Editorial Board members. Authors of unsolicited reviews should first contact an Editor or Editorial Board member to determine whether the proposed article is within the scope of the Journal.Benefits to authors We also provide many author benefits, such as a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center
Biosensors & Bioelectronics has an open access companion journal Biosensors &Bioelectronics: X . To submit to Biosensors & Bioelectronics: X visit https://www.editorialmanager.com/BIOSX/default.aspx.Biosensors are defined as analytical devices incorporating a biological material, a biologically derived material or a biomimic intimately associated with or integrated within a physicochemical transducer or transducing microsystem, which may be optical, electrochemical, thermometric, piezoelectric, magnetic or micromechanical (Turner et al., 1987; Turner, 1989). Biosensors & Bioelectronics is the principal international journal devoted to research, design, development and application of biosensors and bioelectronics. It is an interdisciplinary journal serving professionals with an interest in the exploitation of biological materials and designs in novel diagnostic and electronic devices including sensors, DNA chips, electronic noses, lab-on-a-chip and μ-TAS. Biosensors usually yield a digital electronic signal which is proportional to the concentration of a specific analyte or group of analytes. While the signal may in principle be continuous, devices can be configured to yield single measurements to meet specific market requirements. Examples of Biosensors include immunosensors, enzyme-based biosensors, organism- and whole cell-based biosensors. They have been applied to a wide variety of analytical problems including uses in medicine, biomedical research, drug discovery, the environment, food, process industries, security and defence. The design and study of molecular and supramolecular structures with molecular biorecognition and biomimetic properties for use in analytical devices is also included within the scope of the journal. Here the focus is on the complementary intersection between molecular recognition, nanotechnology, molecular imprinting and supramolecular chemistry to improve the analytical performance and robustness of devices.The emerging field of Bioelectronics seeks to exploit biology in conjunction with electronics in a wider context encompassing, for example, biological fuel cells, bionics and biomaterials for information processing, information storage, electronic components and actuators. A key aspect is the interface between biological materials and micro- and nano-electronics.While endeavouring to maintain coherence in the scope of the journal, the editors will accept reviews and papers of obvious relevance to the community, which describe important new concepts, underpin understanding of the field or provide important insights into the practical application, manufacture and commercialisation of biosensors and bioelectronics.
Cell Chemical Biology (originally Chemistry & Biology) is a Cell Press journal that aims to publish and promote the most important advances in chemical biology with integrity, responsiveness, fairness, and friendliness. Chemical biology is a multidisciplinary discipline that harnesses chemical principles to discover the molecular mechanisms of biological function and disease etiology and develop solutions for life sciences, biotechnology, and human health.Cell Chemical Biology encourages submission of basic, translational, and clinical research articles that provide significant conceptual advancements of broad general interest to researchers within the biological sciences, the biomedical sciences, and associated fields. Research areas that we consider within our scope include but are not limited to cancer biology, immunology, cell biology, microbiology, virology, RNA biology, synthetic biology, protein engineering, genome editing, drug discovery, metabolism, and physiology.We are interested in papers that report molecular mechanisms underlying cellular processes or disease biology, those that report new therapeutics derived from utilizing chemical biology tools, and those that report technologies that perturb, visualize, or measure biological processes. Examples of chemical or molecular tools include but are not confined to nucleic acids and/or their modifications, small molecules, antibodies, biologics, probes, engineered proteins, metabolites, lipids, sugars, and post-translational modifications.We also welcome submissions reporting significant technical advancements in molecular probes, sensors, tools, and technologies, including a proof-of-principle demonstration that the new methodology/tool will help address important questions in biomedical research that are of interest to our broad readership (from basic scientists to clinicians).For further clarifications or questions about our aims and scope, please feel welcome to contact us at [email protected] or email editors directly. You can also submit your manuscript as a presubmission inquiry.Visit the Cell Press website for more information about Cell Chemical Biology - http://www.cell.com/cell-chemical-biology/home
The Tetrahedron Family of journals are the home for organic chemists across disciplines and around the globe. We are building on a legacy of publishing excellence and offering dedicated editorial support and expert peer review; the choice to publish your work as open access or subscription; multiple article types; speed to publication; and unparalleled reach and visibility.Tetrahedron welcomes researchers from academia and industry and publishes the following article types: full length research articles, reviews and perspectives.Our scope is focused on but not limited to the following core topics:Catalysis in the broadest sense including: Asymmetric Catalysis, Biocatalysis, Photocatalysis and Electrocatalysis.Green & sustainable approaches to synthesisOrganic & Organometallic chemistry including synthetic methodologyChemical Biology and Bioorganic ChemistryNatural product synthesisSynthesis for drug discoveryAI and machine learning for synthesisFunctional organic and polymeric materialsSupramolecular and macromolecular chemistryBenefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center
The Tetrahedron Family of journals are the home for organic chemists across disciplines and around the globe. We are building on a legacy of publishing excellence and offering dedicated editorial support and expert peer review; the choice to publish your work as open access or subscription; multiple article types; speed to publication; and unparalleled reach and visibility.TETL (Tetrahedron Letters) welcomes researchers from academia and industry and publishes the following article types: short communications, concise review articles and perspectives.Our scope is focused on but not limited to the following core topics: Catalysis in the broadest sense including: Asymmetric Catalysis, Biocatalysis, Photocatalysis and Electrocatalysis.Green & sustainable approaches to synthesisOrganic & Organometallic chemistry including synthetic methodologyChemical Biology and Bioorganic ChemistryNatural product synthesisSynthesis for drug discoveryAI and machine learning for synthesisFunctional organic and polymeric materialsSupramolecular and macromolecular chemistry